Project Leader: Clara D. Bloomfield, MD
The Career Development Program (CDP) is an important component of this Leukemia SPORE application and the national SPORE program because it assures a cadre of academic faculty who are translational scientists dedicated to discovering and applying new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with leukemia. The goal of our CDP is to recruit, provide training and guidance (i.e., mentor and develop) and retain academic faculty level physician-scientists, clinician-investigators, and laboratory-based scientists who will dedicate their endeavors to leukemia translational research.
Success of the program will be judged by the quality of the science generated by the awardees, their success in obtaining external peer-reviewed funding, their success in academic advancement and their retention in academia and leukemia translational research.
Ramiro Garzon, MD, Assistant Professor, Division of Hematology: Targeting miR-155 in cytogenetically normal acute myeloid leukemia with FLT3-ITD mutations—New RO1 and ACS
- Amy J Johnson, PhD, Research Assistant Professor, Division of Hematology: The role of PI3-Kinase in chronic lymphocytic leukemia—New RO1
- Alison Walker, MD, Assistant Professor, Division of Hematology: Dual Targeting of FLT3+ AML
Ralf Bundschuh, PhD, Professor, Department of Physics: Computational Analysis of the Methylome in acute myeloid leukemia
- Jennifer Woyach, MD, Assistant Professor, Division of Hematology: Mechanisms of Resistance to Ibrutinib
- Carlos Castro, PhD, Assistant Professor, Department of Mechanical & Aerospace Engineering: Signaling of CD86 in lymphoid leukemia